Soluções API

Dr. Reddy's API business supplies high-quality, affordable APIs to leading generic formulations manufacturers and is the preferred API partner for pharma companies in more than 100 countries.

R&D

Dr. Reddy’s supplies generic APIs to 80+ countries, excelling in R\&D across niche molecules and key therapies, with capabilities from lab to production in contained/non-contained APIs and advanced chemical processes.

Livro Branco

Dr. Reddy’s offers insightful whitepapers sharing expertise on APIs, formulations, regulatory trends, and industry innovations, helping global pharma partners gain knowledge, solve challenges, and drive faster, compliant product development.

About Decitabine API

Therapeutic Category Oncology
CAS Number
2353-33-5
API Technology
High Potent
Dose Form
Oral Solid/Tablets
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, Brazil DMF, Korea DMF

Request for Quotation

Get in touch with us by filling out the form below. Our team will reach out to you shortly!

Related APIs

Adagrasib

Oncology

Fruquintinib

Oncology

Tucatinib

Oncology

Ripretinib

Oncology

Cabozantinib HCl

Oncology

Cabozantinib S-Malate

Oncology

Carfilzomib

Oncology

Deucravacitinib

Oncology

Acalabrutinib

Oncology

Capivasertib

Oncology

Lenvatinib Mesylate (Form C & MIBK Solvate)

Oncology

Abiraterona Acetato

Oncology

Apalutamide (Amorphous & Form B)

Oncology

Ácido Zoledrônico

Oncology

Azacitidina

Oncology

Cloridrato De Bendamustina

Oncology

Relugolix

Oncology

Bortezomibe

Oncology

Cabazitaxel

Oncology

Capecitabina

Oncology

Pomalidomida

Oncology

Dissódio Pemetrexede (hepta-hidratado)

Oncology

Pazopanib

Oncology

Palbociclibe

Oncology

Dasatinibe

Oncology

Olaparib (Form A)

Oncology

Decitabina

Oncology

Cloridrato De Nilotinibe

Oncology

Midostaurin

Oncology

Enzalutamida

Oncology

Mesilato De Eribulina

Oncology

Gemcitabine Hydrochloride

Oncology

Lenalidomida

Oncology

Lomustina

Oncology

About Decitabine API

Therapeutic Category Oncology

CAS Number

API Technology

Dose Form

Dr Reddy's Development Status

Available Regulatory Filing

Request for Quotation

Related APIs

Adagrasib

Fruquintinib

Tucatinib

Ripretinib

Cabozantinib HCl

Cabozantinib S-Malate

Carfilzomib

Deucravacitinib

Acalabrutinib

Capivasertib

Lenvatinib Mesylate (Form C & MIBK Solvate)

Abiraterona Acetato

Apalutamide (Amorphous & Form B)

Ácido Zoledrônico

Azacitidina

Cloridrato De Bendamustina

Relugolix

Bortezomibe

Cabazitaxel

Capecitabina

Pomalidomida

Dissódio Pemetrexede (hepta-hidratado)

Pazopanib

Palbociclibe

Dasatinibe

Olaparib (Form A)

Decitabina

Cloridrato De Nilotinibe

Midostaurin

Enzalutamida

Mesilato De Eribulina

Gemcitabine Hydrochloride

Lenalidomida

Lomustina

Disclaimer: Products under patent(s) are offered only for R&D purposes U/S 107A of the Patents Act (Bolar Exemption) and not for commercial sale.